CaraVan Biologix

Andover, United States

CaraVan Biologix is a biotechnology company that focuses on expanding the life-saving benefits of CAR-T cell therapeutics.

$1.7M raised

Mar 2022

Seed

Biotechnology Health Care Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CaraVan Biologix

How much funding has CaraVan Biologix raised?

CaraVan Biologix has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in March 2022.

Where is CaraVan Biologix headquartered?

CaraVan Biologix is headquartered in Andover, United States.

What does CaraVan Biologix do?

CaraVan Biologix is a biotechnology company that focuses on expanding the life-saving benefits of CAR-T cell therapeutics.

What stage is CaraVan Biologix at?

CaraVan Biologix is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 22, 2022.

MLA

"CaraVan Biologix — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/caravan-biologix. Accessed July 3, 2026.

APA

VCBacked. (2022). CaraVan Biologix — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/caravan-biologix

Wikipedia (cite web)

{{cite web |title=CaraVan Biologix — Funding & Investors |url=https://www.vcbacked.co/company/caravan-biologix |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 22, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K